Skip to main content
. 2019 Sep 23;11:156–165. doi: 10.1016/j.ijpddr.2019.09.004

Table 1.

Particle size, zeta potential, AmB concentrations, MICa (against L. major promastigotes) and ED50 (against L. major amastigotes in J774 A.1 macrophage) of topical liposomal AmB formulations.

Liposome formulations Z-average (nm) Zeta potential (mv) ± SD AmB concentration (mg/g) ± SD MICa(μg/mL) ED50(μg/mL) (lower and upper 95% limit)
Control empty liposomes 106.3 ± 2.1 −32.9 ± 4.59 Inactive Inactive
Lip-AmB 0.1% 119.2 ± 14.4 −32.7 ± 6.13 1.17 ± 0.0058 0.625 0.151 (0.0523–0.434)
Lip-AmB 0.2% 116.7 ± 9.9 −36.4 ± 7.98 2.36 ± 0.0058 0.625 0.151 (0.085–0.267)
Lip-AmB 0.4% 113.5 ± 10.4 −36.5 ± 4.2 4.11 ± 1.53 0.625 0.0856 (0.0147–0.5)
Fungizone 0.625 0.063 (0.027–0.146)

The values are means ± standard deviations (n = 3).

a

Minimum inhibitory concentrations.